UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis
NYSE:PATH - New York Stock Exchange, Inc. - US90364P1057 - Common Stock - Currency: USD
PATH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. No worries on liquidiy or solvency for PATH as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PATH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PATH was profitable.
In the past year PATH had a positive cash flow from operations.
In the past 5 years PATH always reported negative net income.
In multiple years PATH reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.57%, PATH is in line with its industry, outperforming 57.60% of the companies in the same industry.
PATH's Return On Equity of -3.99% is fine compared to the rest of the industry. PATH outperforms 60.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -3.99% | ||
| ROIC | N/A |
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 82.93%, PATH belongs to the best of the industry, outperforming 90.46% of the companies in the same industry.
In the last couple of years the Gross Margin of PATH has remained more or less at the same level.
PATH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
2. Health
2.1 Basic Checks
PATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
PATH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PATH has more shares outstanding
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.02 indicates that PATH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.02, PATH is in the better half of the industry, outperforming 63.96% of the companies in the same industry.
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.02 |
ROIC/WACCN/A
WACC11.05%
2.3 Liquidity
PATH has a Current Ratio of 2.93. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.93, PATH is doing good in the industry, outperforming 74.91% of the companies in the same industry.
A Quick Ratio of 2.93 indicates that PATH has no problem at all paying its short term obligations.
PATH has a better Quick ratio (2.93) than 75.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.93 | ||
| Quick Ratio | 2.93 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.00% over the past year.
Measured over the past years, PATH shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
Looking at the last year, PATH shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
Measured over the past years, PATH shows a very strong growth in Revenue. The Revenue has been growing by 33.58% on average per year.
EPS 1Y (TTM)0%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%4.54%
3.2 Future
PATH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.84% yearly.
PATH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.61% yearly.
EPS Next Y1.85%
EPS Next 2Y5.71%
EPS Next 3Y4.43%
EPS Next 5Y1.84%
Revenue Next Year6.64%
Revenue Next 2Y7.81%
Revenue Next 3Y8.27%
Revenue Next 5Y11.61%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
PATH is valuated rather expensively with a Price/Earnings ratio of 22.91.
75.62% of the companies in the same industry are more expensive than PATH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.82. PATH is around the same levels.
PATH is valuated rather expensively with a Price/Forward Earnings ratio of 22.49.
PATH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PATH is cheaper than 72.08% of the companies in the same industry.
PATH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.91 | ||
| Fwd PE | 22.49 |
4.2 Price Multiples
PATH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PATH is cheaper than 78.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.32 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)12.4
PEG (5Y)N/A
EPS Next 2Y5.71%
EPS Next 3Y4.43%
5. Dividend
5.1 Amount
No dividends for PATH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
12.37
+0.03 (+0.24%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners66.97%
Inst Owner Change3.36%
Ins Owners7.05%
Ins Owner Change0.25%
Market Cap6.62B
Analysts65.81
Price Target12.2 (-1.37%)
Short Float %9.91%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.25%
Min EPS beat(2)27.1%
Max EPS beat(2)47.41%
EPS beat(4)4
Avg EPS beat(4)26.15%
Min EPS beat(4)10.35%
Max EPS beat(4)47.41%
EPS beat(8)8
Avg EPS beat(8)92.57%
EPS beat(12)12
Avg EPS beat(12)105.9%
EPS beat(16)16
Avg EPS beat(16)107.11%
Revenue beat(2)1
Avg Revenue beat(2)-1.18%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)0%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)2.1%
Revenue beat(8)5
Avg Revenue beat(8)0.96%
Revenue beat(12)9
Avg Revenue beat(12)2.46%
Revenue beat(16)13
Avg Revenue beat(16)2.84%
PT rev (1m)-2.47%
PT rev (3m)-23.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.85%
EPS NY rev (1m)0.01%
EPS NY rev (3m)4.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.62%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.91 | ||
| Fwd PE | 22.49 | ||
| P/S | 4.77 | ||
| P/FCF | 22.32 | ||
| P/OCF | 21.28 | ||
| P/B | 3.7 | ||
| P/tB | 3.9 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.54
EY4.37%
EPS(NY)0.55
Fwd EY4.45%
FCF(TTM)0.55
FCFY4.48%
OCF(TTM)0.58
OCFY4.7%
SpS2.59
BVpS3.35
TBVpS3.17
PEG (NY)12.4
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -3.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.93% | ||
| FCFM | 21.38% |
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 86.6% | ||
| Cap/Sales | 1.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.93 | ||
| Quick Ratio | 2.93 | ||
| Altman-Z | 4.02 |
F-Score6
WACC11.05%
ROIC/WACCN/A
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y1.85%
EPS Next 2Y5.71%
EPS Next 3Y4.43%
EPS Next 5Y1.84%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%4.54%
Revenue Next Year6.64%
Revenue Next 2Y7.81%
Revenue Next 3Y8.27%
Revenue Next 5Y11.61%
EBIT growth 1Y14.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.25%
EBIT Next 3Y22.19%
EBIT Next 5Y22.63%
FCF growth 1Y4.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.18%
OCF growth 3YN/A
OCF growth 5YN/A